Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Evaluation of the Use of Topically Administered Danazol Versus Placebo in Subjects With Pain Associated With Fibrocystic Breast Disease

NCT00744276 is registered in ClinicalTrials.gov with FemmePharma Global Healthcare, Inc. as lead sponsor.

NCT NCT00744276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00744276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Evaluation of the Use of Topically Administered Danazol Versus Placebo in Subjects With Pain Associated With Fibrocystic Breast Disease
Lead sponsor
FemmePharma Global Healthcare, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
June 30, 2009
Enrollment
60 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

fibrocystic disease of breast